Refine by
Oncology Software In Usa
44 software items found
by:Eidogen-Sertanty, Inc. based inOceanside, CALIFORNIA (USA)
The Oncology Knowledgebase (OKB) is Eidogen-Sertanty's database of structure-activity data across numerous targets of oncological interest. Nicely complementing the Kinase Knowledgebase (KKB), the OKB will cover a broad spectrum of targets relevant to Colon cancer, Esophageal cancer, Glioma, Head and Neck cancer, Kidney cancer, Leukemia, Liver cancer, Lung ...
Manufactured by:Varian Medical Systems, Inc. based inPalo Alto, CALIFORNIA (USA)
Efficient, distributed, radiation therapy peer ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of novel (partner-agnostic) fusions and exon skipping events, even with minimal RNA ...
by:Echelon Diagnostics based inReno, NEVADA (USA)
Through cell-free DNA testing technology, EchelonDx leverages next-generation sequencing data to provide new approaches toward improving oncology patient ...
Manufactured by:Varian Medical Systems, Inc. based inPalo Alto, CALIFORNIA (USA)
Fast, precise planning for advanced cancer care. The Eclipse treatment planning system has been developed and advanced with the collaboration of clinicians to be better able to treat their patients. Thousands of hospitals and cancer treatment centers of all sizes trust Eclipse for their treatment planning ...
by:NantHealth, Inc. based inMorrisville, NORTH CAROLINA (USA)
For clinicians, Eviti Advisor grants access to Eviti’s vast evidence-based treatment library, providing thorough details on the effectiveness, side effects, and cost of potential cancer treatments. Cancer research is ever-evolving. Often, physicians struggle to manage overwhelming amounts of information around the risks, benefits, and trade-offs of different treatment options. Time is of ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately risks limiting researchers’ productivity, thus ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop inherited cancer depends on the ability to characterize genes ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Genomic profiling is driving precision oncology. From targeted to comprehensive solutions, Next-Generation-Sequencing (NGS) offers the capacity to simultaneously analyze a select set of genes, regions, and biomarkers based on known involvement across solid tumor such as lung, colon, breast, melanoma, gastric, and ovarian cancers. ...
by:MIM Software Inc. based inCleveland, OHIO (USA)
Accuracy and time savings are prerequisites for deep learning AI techniques. Contour ProtégéAI is a truly impactful auto-contouring solution that also addresses your clinical workflow bottlenecks and allows for seamless ...
by:MIM Software Inc. based inCleveland, OHIO (USA)
Image Registration for Contouring and Prior Treatment Assessment; When clinicians complete use cases within Maestro, they create better treatment plans. Maestro lays the foundation for improved treatment planning by creating accurate, easily accessible imaging data to help clinicians form a comprehensive understanding of prior therapy history and a patient’s current disease. It is a ...
by:MIM Software Inc. based inCleveland, OHIO (USA)
MIM Symphony LDR allows for MRI and CT-guided planning for prostate. It is a fully-featured solution without add-on ...
by:NantHealth, Inc. based inMorrisville, NORTH CAROLINA (USA)
Payers, seeking a clearer view into treatment validity, turn to Eviti Connect. Focused on high-quality, high-value care, the platform offers insight payers need to make reimbursement decisions. For payers, Eviti Connect streamlines the authorization of cancer treatment, ensuring prescription of high-quality, high-value care and setting patients on the path to appropriate treatment sooner. ...
by:NantHealth, Inc. based inMorrisville, NORTH CAROLINA (USA)
Reimburse High-Quality, High-Value Autoimmune Care with Confidence. Providers don’t want to delay patient care. Payers don’t want to waste money on unwarranted, ineffective autoimmune care. Both want to improve clinical outcomes while ensuring healthcare dollars are spent ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Maximize your biologically actionable insights from small tumor samples with the SOPHiA DDM™ RNAtarget Technology end-to-end solutions. Gene fusions have been associated with various tumors and are recognized as valuable cancer biomarkers in cancer research1. Targeted RNA sequencing is recommended to maximize novel fusion detection by identifying transcribed and potentially actionable ...
by:NantOmics based inMorrisville, NORTH CAROLINA (USA)
Eviti Connect® is an evidence-based decision support and treatment validation platform that gives providers and payers confidence to prescribe and reimburse high-quality, high-value oncology and autoimmune ...
by:Inspirata, Inc based inTampa, FLORIDA (USA)
NLP-based AI for automated cancer datasets and registry reporting. Inspirata’s E-Path suite of cancer registry automation solutions is powered by an oncology-specific Natural Language Processing (NLP) based artificial intelligence fine-tuned for cancer reporting. While complementing existing workflows, E-Path removes operator variability and far exceeds human performance in ...
by:BioDiscovery, A Bionano Genomics Company based inEl Segundo, CALIFORNIA (USA)
The MSR algorithm can be applied to any gene panel from single gene (e.g. DMD test) to large panels having thousands of gene. The image below is from the Illumina TruSightTM Oncology 500 (TSO500) panel showing a somatic cancer profile. The cytogenetic complexity of the tumor sample is clearly evident with a large copy number gain of 8p and loss of a large section of 13q. ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
Indica Labs’ Multiplex IHC module separates up to five stains simultaneously within any cellular compartment (nucleus, cytoplasm or membrane) and can be used for a variety of IHC applications. This module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize distinct immune and tumor cell populations within the tissue. ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
With unmatched ease-of-use and scalability, powerful analytic capabilities, and the fastest processing speeds available for digital pathology, pharmaceutical, healthcare and research organizations worldwide are using HALO for high-throughput, quantitative tissue analysis in oncology, neuroscience, metabolism, toxicology and more. ...